Premium
Gastrointestinal: Pembrolizumab‐induced gastric ulcer occurring as an immune‐related adverse event
Author(s) -
Terasaki K,
Ueno A,
Mizuno C,
Shima T,
Okanoue T
Publication year - 2022
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.15788
Subject(s) - medicine , pembrolizumab , gastroenterology , stomach , esophagogastroduodenoscopy , cancer , helicobacter pylori , adverse effect , chemotherapy , endoscopy , immunotherapy